共 18 条
[1]
KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney disease improving global outcomes(KDIGO)blood pressure work group. Kidney inter.Suppl . 2012
[2]
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Staessen JA,Fagard R,Thijs L,et al. The Lancet . 1997
[3]
KDOQITM Clinical Practice Guidelines And Clinical Practice Recommendations For Diabetes And Chronic Kidney Disease. National Kidney Foundation. American Journal of Kidney Diseases . 2007
[4]
Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. Bakris G L,Weir M R,Shanifar S,et al. Archives of Internal Medicine . 2003
[5]
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
[J].
LANCET,
1997, 350 (9080)
:757-764
Staessen, JA
;
Fagard, R
;
Thijs, L
;
Celis, H
;
Arabidze, GG
;
Birkenhager, WH
;
Bulpitt, CJ
;
deLeeuw, PW
;
Dollery, CT
;
Fletcher, AE
;
Forette, F
;
Leonetti, G
;
Nachev, C
;
OBrien, ET
;
Rosenfeld, J
;
Rodicio, JL
;
Tuomilehto, J
;
Zanchetti, A
.
[6]
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Dahl?f Bj?rn,Devereux Richard B,Kjeldsen Sverre E,Julius Stevo,Beevers Gareth,de Faire Ulf,Fyhrquist Frej,Ibsen Hans,Kristiansson Krister,Lederballe-Pedersen Ole,Lindholm Lars H,Nieminen Markku S,Omvik Per,Oparil Suzanne,Wedel Hans. The Lancet . 2002
[7]
2014 evidence-based guideline for the management of high blood pressure in adults report from the panel members appointed to the Eighth Joint National Committee (JNC 8). Jarnes PA,Oparil S,Carter BL,et al. The Journal of The American Medical Association . 2014
[8]
Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. The MICRO-HOPE Study. Microalbuminuria, cardiovascular, and renal outcomes. Heart Outcomes Preven. Gerstein H C,Bosch J,Pogue J,Taylor D W,Zinman B,Yusuf S. Diabetes Care . 1996
[9]
Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Tzourio Christophe,Anderson Craig,Chapman Neil,Woodward Mark,Neal Bruce,MacMahon Stephen,Chalmers John. Archives of Internal Medicine . 2003
[10]
Effects of intensive blood-pressure control in type 2 diabetes mellitus. Cushman William C,Evans Gregory W,Byington Robert P,Goff David C,Grimm Richard H,Cutler Jeffrey A,Simons-Morton Denise G,Basile Jan N,Corson Marshall A,Probstfield Jeffrey L,Katz Lois,Peterson Kevin A,Friedewald William T,Buse John B,Bigger. The New England Quarterly . 2010